Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2011-1-21
pubmed:abstractText
The SEISMIC study was an open-label, prospective, randomised study to assess the safety and feasibility of percutaneous myoblast implantation in heart failure patients with implanted cardioverter-defibrillators (ICD).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1969-6213
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
805-12
pubmed:meshHeading
pubmed-meshheading:21252013-Adult, pubmed-meshheading:21252013-Aged, pubmed-meshheading:21252013-Amiodarone, pubmed-meshheading:21252013-Anti-Arrhythmia Agents, pubmed-meshheading:21252013-Arrhythmias, Cardiac, pubmed-meshheading:21252013-Cells, Cultured, pubmed-meshheading:21252013-Disease Progression, pubmed-meshheading:21252013-Electrocardiography, Ambulatory, pubmed-meshheading:21252013-Exercise Tolerance, pubmed-meshheading:21252013-Female, pubmed-meshheading:21252013-Heart Failure, pubmed-meshheading:21252013-Humans, pubmed-meshheading:21252013-Injections, pubmed-meshheading:21252013-Male, pubmed-meshheading:21252013-Middle Aged, pubmed-meshheading:21252013-Myoblasts, Skeletal, pubmed-meshheading:21252013-Myocardium, pubmed-meshheading:21252013-Stroke Volume, pubmed-meshheading:21252013-Transplantation, Autologous, pubmed-meshheading:21252013-Ventricular Function, Left
pubmed:year
2011
pubmed:articleTitle
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial.
pubmed:affiliation
Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands. h.duckers@erasmusmc.nl
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II